ACELARATE: A randomised phase III, open label, clinical study comparing NUC-1031 with gemcitabine in patients with metastatic pancreatic carcinoma
Authors
Harrison, Palmer DRoss, PJ
Silcocks, P
Greenhalf, W
Faluyi, O
Ma, YT
Wadsley, J
Rawcliffe, C
Neoptolemos, J
Valle, Juan W
Wasan, H
Starling, N
Patel, K
Bridgewater, J
Affiliation
Liverpool Cancer Trials Unit, University of Liverpool, Liverpool, UKIssue Date
2018
Metadata
Show full item recordCitation
Harrison Palmer D, Ross PJ, Silcocks P, Greenhalf W, Faluyi O, Ma YT, et al. 788TiP ACELARATE: A randomised phase III, open label, clinical study comparing NUC-1031 with gemcitabine in patients with metastatic pancreatic carcinoma. Annals of Oncology. 2018;29(suppl_8).Journal
Annals of OncologyDOI
10.1093/annonc/mdy282.171PubMed ID
No PMIDAdditional Links
https://dx.doi.org/10.1093/annonc/mdy282.171Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1093/annonc/mdy282.171